Search

Author/Creator Palackdharry, Sarah

1. 809 Phase 2 trial of neoadjuvant and adjuvant PD-1 checkpoint blockade in local-regionally advanced, resectable HNSCC indicates pathological response is associated with high disease-free survival. (9th November 2020)

Authors:
Wise-Draper, Trisha; Gulati, Shuchi; Takiar, Vinita; Palackdharry, Sarah; Worden, Francis; Old, Matthew; Kaczmar, John; Dunlap, Neal; Hinrichs, Benjamin; Bell, Diana; Patil, Yash; Riaz, Muhammad Kashif; Weatherford, Layne; Hamilton, Aubrey; Lanverman, Sheena; Mierzwa, Michelle; Casper, Keith; Mar...
Journal:
Journal for immunotherapy of cancer
Issue:
Volume 8(2020)Supplement 3
Page Start:
A484
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. 809 Phase 2 trial of neoadjuvant and adjuvant PD-1 checkpoint blockade in local-regionally advanced, resectable HNSCC indicates pathological response is associated with high disease-free survival. (9th November 2020)

Authors:
Wise-Draper, Trisha; Gulati, Shuchi; Takiar, Vinita; Palackdharry, Sarah; Worden, Francis; Old, Matthew; Kaczmar, John; Dunlap, Neal; Hinrichs, Benjamin; Bell, Diana; Patil, Yash; Riaz, Muhammad Kashif; Weatherford, Layne; Hamilton, Aubrey; Lanverman, Sheena; Mierzwa, Michelle; Casper, Keith; Mar...
Journal:
Journal for immunotherapy of cancer
Issue:
Volume 8(2020)Supplement 3
Page Start:
A859
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. Glutaminase inhibition with telaglenastat (CB-839) improves treatment response in combination with ionizing radiation in head and neck squamous cell carcinoma models. (1st April 2021)

Authors:
Wicker, Christina A.; Hunt, Brian G.; Krishnan, Sunil; Aziz, Kathryn; Parajuli, Shobha; Palackdharry, Sarah; Elaban, William R.; Wise-Draper, Trisha M.; Mills, Gordon B.; Waltz, Susan E.; Takiar, Vinita
Journal:
Cancer letters
Issue:
Volume 502(2021)
Page Start:
180
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. Metformin increases natural killer cell functions in head and neck squamous cell carcinoma through CXCL1 inhibition. Issue 11 (3rd November 2022)

Authors:
Crist, McKenzie; Yaniv, Benyamin; Palackdharry, Sarah; Lehn, Maria A; Medvedovic, Mario; Stone, Timothy; Gulati, Shuchi; Karivedu, Vidhya; Borchers, Michael; Fuhrman, Bethany; Crago, Audrey; Curry, Joseph; Martinez-Outschoorn, Ubaldo; Takiar, Vinita; Wise-Draper, Trisha M
Journal:
Journal for immunotherapy of cancer
Issue:
Volume 10:Issue 11(2022)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗